The board of directors at Sensorion has a history of experience in finance, neuroscience, and environmental health. They have also held positions at various companies, such as Bpifrance, CDC Entreprises, Sofinnova Partners, Oddo & Cie, Bryan Garnier & Co, Natixis Securities, Institut Pasteur-Institut de l'Audition, University of Nottingham, School of Medicine, ECN Academy, Fondation Pour l'Audition, QBM LMU Munich, National Institute of Genetics, Japan, Harvard University, HelmholtzZentrum München, Neumann University, Imvax, Inc., Adaptimmune, Spark Therapeutics, Inc., axial biotherapeutics, inc., siolta therapeutics, a-mansia biotech, biomx ltd., and the invus group.
View all